Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HiBEAM was a Honolulu-based startup studio, accelerator, and incubator created to help launch and build high-growth technology, biotechnology, and life sciences companies in Hawaii. Rather than operating as a drug developer, the organization provided company-building support, professional advisory services, and access to funding sources for early-stage ventures. Public business-directory and investor-profile sources describe HiBEAM as founded in 2000, headquartered in Honolulu, and associated with a portfolio that included healthcare and biotech-related companies such as Hawaii Biotech, Cardax, and OneMedNet. The entity appears to have been inactive or out of business in later investor databases. Because HiBEAM was primarily an incubator rather than a therapeutic-product company, conventional biotech pipeline fields such as modalities, targets, indications, and clinical stage do not meaningfully apply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HiBEAM.